Trusted Resources: Education
Scientific literature and patient education texts
Marked Progress in AL Amyloidosis Survival: A 40-Year Longitudinal Natural History Study
source: Blood Cancer Journal
year: 2021
authors: A. Staron, L. Zheng, G. Doros, L.H. Connors, L.M. Mendelson, T. Joshi, V. Sanchorawala
summary/abstract:The recent decades have ushered in considerable advancements in the diagnosis and treatment of systemic light chain (AL) amyloidosis. As disease outcomes improve, AL amyloidosis-unrelated factors may impact mortality. In this study, we evaluated survival trends and primary causes of death among 2337 individuals with AL amyloidosis referred to the Boston University Amyloidosis Center. Outcomes were analyzed according to date of diagnosis: 1980-1989 (era 1), 1990-1999 (era 2), 2000-2009 (era 3), and 2010-2019 (era 4). Overall survival increased steadily with median values of 1.4, 2.6, 3.3, and 4.6 years for eras 1-4, respectively (P < 0.001). Six-month mortality decreased over time from 23% to 13%. Wide gaps in survival persisted amid patient subgroups; those with age at diagnosis ≥70 years had marginal improvements over time. Most deaths were attributable to disease-related factors, with cardiac failure (32%) and sudden unexpected death (23%) being the leading causes. AL amyloidosis-unrelated mortality increased across eras (from 3% to 16% of deaths) and with longer-term survival (29% of deaths occurring >10 years after diagnosis). Under changing standards of care, survival improved and early mortality declined over the last 40 years. These findings support a more optimistic outlook for patients with AL amyloidosis.
organization: Boston University School of Medicine and Boston Medical Center, USA; Boston University School of Public Health, USADOI: 10.1038/s41408-021-00529-w
read more full text
Related Content
-
Webinar Presentation by Angela Dispenzieri on the Treatment of Light Chain (AL) Amyloidosishttps://www.youtube.com/watch?v=8k7eubg5...
-
How Can I Avoid Fluid Balance Problems?Many patients with AL amyloidosis should...
-
What is New in Diagnosis and Management of Light Chain Amyloidosis?Light chain (AL) amyloidosis is caused b...
-
AL Amyloidosis Treatment Including Stem Cell Transplantationhttps://www.youtube.com/watch?v=f6kSzKge...
-
Q&A Session 1 – ASG Webinar 4/13https://www.youtube.com/watch?v=NrEjyVeJ...
-
The Challenges in Chemotherapy and Stem Cell Transplantation for Light-Chain AmyloidosisLight-chain (AL) amyloidosis is a system...
-
Financial Assistance for AL Patients – ASG Webinar 5/13https://www.youtube.com/watch?v=4gUXPbOk...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.